by Leukemia
Manufacturing chimeric antigen receptor (CAR) T cells in galactose-based media amplifies their mitochondrial activity, thus enhancing their efficacy, according to research.
by Blood
A new approach for graft-versus-host disease (GVHD) prevention after hematopoietic stem cell transplantation (HSCT) centers around the tissue injury that occurs during pre-procedure cytotoxic...
by Dr. Corey Cutler, MD, MPH
In June's President's Message, Dr. Corey Cutler, MD, MPH, highlights the importance of World Sickle Cell Day and the progress made in treating the disease through cell therapies,...
by Alex Kadhim
In a collaborative effort between 18 centers, researchers have developed a system that effectively stratifies children at the onset of acute graft versus host disease (GVHD) for risk of...
by Alex Kadhim
Researchers at the Mayo Clinic have found that mesenchymal stromal cells (MSCs) engineered with chimeric antigen receptors (CARs) can enhance immunosuppression in the context of immune-related...
by Alex Kadhim
A new framework for optimizing immune therapy in multiple myeloma (MM) based on distinct spatial immune types of the disease has been proposed by the Winship Center for Cancer Immunology at Emory...